Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_12312
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 12312
Character Range: 798266–799635

12312                                                            Bone densitometry, using dual energy X‑ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting) for diagnosis and monitoring of bone loss associated with one or more of the following:                                                                                                                                                                                                                                                                                                                                    106.55
                                                                 (a) prolonged glucocorticoid therapy;
                                                                 (b) any condition associated with excess glucocorticoid secretion;
                                                                 (c) male hypogonadism;
                                                                 (d) female hypogonadism lasting more than 6 months before the age of 45;
                                                                 other than a service associated with a service to which item 12306, 12315 or 12321 applies
                                                                 For any particular patient, once only in a 12 month period